DEGUSSA COMPLETING PURCHASE OF AWD

13 January 1992

In a report issued by the directors of Germany's Degussa, the company noted that (subject to final approval by the administration board of the Treuhand eastern German privatization agency and by the anti-trust authorities) Degussa is acquiring Arzneimittelwerk Dresden GmbH.

The statement said that Degussa's affiliate Asta Medica AG won the bid under an internationalization privatization tender sponsored by the Treuhand. With 2,000 employees and sales of over 400 million Deutschemarks ($263.9 million), AWD is the largest producer of pharmaceuticals in eastern Germany. The company focuses principally on treatments for cardiovascular, gastrointestinal, rheumatic and central nervous system disorders.For Asta, this acquisition represents an entree into the market for branded generics and expansion into the new eastern sector.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight